Loading…
U.S. Nuclear Weapons in Europe: Critical for Transatlantic Security
Since the end of the Cold War, the U.S. nuclear weapons posture has undergone a dramatic change. The U.S. has withdrawn about 90 percent of its forward-deployed nuclear weapons from Europe. In 2013, the Obama Administration initiated the Life Extension Program (LEP) for the B61 tactical nuclear weap...
Saved in:
Published in: | Policy File 2014 |
---|---|
Main Author: | |
Format: | Report |
Language: | English |
Subjects: | |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Since the end of the Cold War, the U.S. nuclear weapons posture has undergone a dramatic change. The U.S. has withdrawn about 90 percent of its forward-deployed nuclear weapons from Europe. In 2013, the Obama Administration initiated the Life Extension Program (LEP) for the B61 tactical nuclear weapon, which is the last nuclear weapon the U.S. keeps in Europe, and the only remaining tactical nuclear weapon in the U.S. arsenal. The LEP will extend the life of the B61 by 20 to 30 years, and could cost over $8 billion. The U.S. and NATO have a continued interest in maintaining the U.S. nuclear presence in Europe since U.S. weapons contribute to the cohesion of the alliance. The U.S. must maintain a strong position in order to protect its national security interests, assure allies, and deter adversaries. It must increase U.S. military strength and develop capabilities that allow it to pursue a "protect and defend" strategy. The B61 LEP is a part of that strategy. The LEP and B61 are important for maintaining a science and technology base that allows the U.S. to keep its weapons safe, secure, and reliable. It will also maintain a U.S. commitment to transatlantic security. |
---|